Tag Archives: Clinical Endo-Cannabinoid Deficiency

Cannalogix Partners with Anantlife to Become the First Research Institute in The US to Offer DNA Tests for Cannabis Side Effects

PORTLAND, Ore., Feb. 27, 2018 /Weed Wire/ — A joint-collaboration that started earlier this year between Anantlife’s Dr. Rahul Kushwah and Cannalogix Foundation’s Chief Research Officer, J.B. Creel – on behalf of all patients seeking relief from the systemic effects of an imbalanced Endo-Cannabinoid System (ECS), has resulted in creation of the world’s first genetic kit measuring a Clinical Endo-Cannabinoid Deficiency (CECD).